AIMS: To estimate the prevalence of Usher syndrome in the city of Birmingham, and to establish a database of patients who have been classified into different clinical subtypes essential for future gene mutation analysis. METHODS: Symptomatic cases of Usher syndrome (US) resident in the city of Birmingham in June 1994 were ascertained through multiple sources. Ophthalmic and audiological reassessment together with examination of medical records and patient questionnaires allowed classification of three subtypes, US 1, US 2, and US 3. In addition, family pedigrees were examined and blood was taken from index patients for DNA extraction. RESULTS: In the population aged over 15 years the prevalence was 6.2 per 100 000 population for all US subtypes. The prevalence for US 1 and US 2 was 5.3 per 100 000 population. This is greater than previously reported. In the age group 30-49 years the prevalence approached 1 in 10 000. Clinical classification found 33% US 1, 47% US 2, and 20% US 3. CONCLUSION: This higher prevalence rate and greater frequency of US 2 and US 3 may reflect a more complete ascertainment.
AIMS: To estimate the prevalence of Usher syndrome in the city of Birmingham, and to establish a database of patients who have been classified into different clinical subtypes essential for future gene mutation analysis. METHODS: Symptomatic cases of Usher syndrome (US) resident in the city of Birmingham in June 1994 were ascertained through multiple sources. Ophthalmic and audiological reassessment together with examination of medical records and patient questionnaires allowed classification of three subtypes, US 1, US 2, and US 3. In addition, family pedigrees were examined and blood was taken from index patients for DNA extraction. RESULTS: In the population aged over 15 years the prevalence was 6.2 per 100 000 population for all US subtypes. The prevalence for US 1 and US 2 was 5.3 per 100 000 population. This is greater than previously reported. In the age group 30-49 years the prevalence approached 1 in 10 000. Clinical classification found 33% US 1, 47% US 2, and 20% US 3. CONCLUSION: This higher prevalence rate and greater frequency of US 2 and US 3 may reflect a more complete ascertainment.
Authors: C G Möller; W J Kimberling; S L Davenport; I Priluck; V White; K Biscone-Halterman; L M Odkvist; P E Brookhouser; G Lund; T J Grissom Journal: Laryngoscope Date: 1989-01 Impact factor: 3.325
Authors: W J Kimberling; C G Möller; S L Davenport; G Lund; T J Grissom; I Priluck; V White; M D Weston; K Biscone-Halterman; P E Brookhouser Journal: Laryngoscope Date: 1989-01 Impact factor: 3.325
Authors: W J Kimberling; M D Weston; C Möller; S L Davenport; Y Y Shugart; I A Priluck; A Martini; M Milani; R J Smith Journal: Genomics Date: 1990-06 Impact factor: 5.736
Authors: W J Kimberling; C G Möller; S Davenport; I A Priluck; P H Beighton; J Greenberg; W Reardon; M D Weston; J B Kenyon; J A Grunkemeyer Journal: Genomics Date: 1992-12 Impact factor: 5.736
Authors: J Kaplan; S Gerber; D Bonneau; J M Rozet; O Delrieu; M L Briard; H Dollfus; I Ghazi; J L Dufier; J Frézal Journal: Genomics Date: 1992-12 Impact factor: 5.736
Authors: M L Tamayo; J E Bernal; G E Tamayo; J L Frias; G Alvira; O Vergara; V Rodriguez; J I Uribe; J C Silva Journal: Clin Genet Date: 1991-10 Impact factor: 4.438
Authors: Terri L McGee; Babak Jian Seyedahmadi; Meredith O Sweeney; Thaddeus P Dryja; Eliot L Berson Journal: J Med Genet Date: 2010-05-27 Impact factor: 6.318
Authors: T Jaijo; E Aller; M Beneyto; C Najera; C Graziano; D Turchetti; M Seri; C Ayuso; M Baiget; F Moreno; C Morera; H Perez-Garrigues; J M Millan Journal: J Med Genet Date: 2007-03 Impact factor: 6.318
Authors: Inga Ebermann; Hendrik P N Scholl; Peter Charbel Issa; Elvir Becirovic; Jürgen Lamprecht; Bernhard Jurklies; José M Millán; Elena Aller; Diana Mitter; Hanno Bolz Journal: Hum Genet Date: 2006-12-15 Impact factor: 4.132
Authors: Denise Yan; Xiaomei Ouyang; D Michael Patterson; Li Lin Du; Samuel G Jacobson; Xue-Zhong Liu Journal: J Hum Genet Date: 2009-10-30 Impact factor: 3.172
Authors: Mohsin Shahzad; Theru A Sivakumaran; Tanveer A Qaiser; Julie M Schultz; Zawar Hussain; Megan Flanagan; Munir A Bhinder; Diane Kissell; John H Greinwald; Shaheen N Khan; Thomas B Friedman; Kejian Zhang; Saima Riazuddin; Sheikh Riazuddin; Zubair M Ahmed Journal: Otolaryngol Head Neck Surg Date: 2013-06-14 Impact factor: 3.497